Starting Technology in At Risk Type 1 Diabetes Study

This study is looking at how a Hybrid Closed Loop Insulin Pump System (an automated insulin delivery system) might help adults with Type 1 Diabetes who have difficulty managing their blood sugar (A1c over 8.5%). The goal is to see if this technology can make managing diabetes easier and improve health outcomes for people who haven't used an insulin pump before. The study aims to include a diverse group of 40 participants. Researchers will measure how many people are eligible and how many join the study within six months to understand how to better include more people in future diabetes technology trials.

Study design
This is an interventional study planning to enroll 40 participants. It is a pilot randomized controlled trial (RCT).
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
The study measures eligibility and enrollment over 6 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06453928

Starting Technology in At Risk Type 1 Diabetes Study

Recruiting
NAAges 18+InterventionalHealth services
University of California, Los Angeles
~40 participants
Updated 2026-02-13 on ClinicalTrials.gov
What's tested:Hybrid Closed Loop Insulin Pump System

At a glance

Recruiting sites
3 of 3 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Proportion of screened participants that are eligible
Measured over 6 months
+6 more outcomes measured
Diabetes Mellitus, Type 1
3 sites across 1 states
California3

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Type 1 Diabetes
A1c \>8.5%
Not insulin pump user
Primary language of English or Spanish
Have medical insurance coverage

Exclusion

No measured A1c in the past year
Have comorbidities that can result in inaccurate hemoglobin A1c
Have cognitive, physical or mental impairment precluding diabetes technology use
Limited life expectancy (\<1 year)
Pregnancy
  • Proportion of screened participants that are eligible6 months

    Eligible among screened, enrolled among eligible, excluded among screened (and why) based on screening, recruitment and enrollment data.

  • Proportion of enrolled participants that are randomized6 months

    Randomized among enrolled, and receiving allocated intervention among randomized.

  • Proportion of average time delay to enrollment6 months

    Average time delay from screening to enrollment.

  • Proportion of retention among participants randomized to the Intervention Group6 months

    Retention among participants receiving allocated intervention after being randomized and discontinued intervention among randomized.

  • Proportion of retention among participants randomized6 months

    Participants lost to follow-up among those initially randomized.

  • Proportion of retention among participants randomized6 months

    Retention rates by participants completing all research assessments among randomized.

  • Number of participants who adhere to assigned treatment6 months

    Treatment-specific adherence, Adherence to study protocol and Proportion of planned assessments that are completed. Fidelity, which pertains to guaranteeing that the intervention is delivered in accordance with the established protocol, will be summarized by study arms, and differences between arms will be examined using t-tests or two-sample tests of proportions as appropriate. Adherence, which relates to the extent to which participants follow the treatment and study protocol, as well as the proportion of planned assessments completed, will be summarized by study arms, and differences between arms will be examined using t-tests or two-sample tests of proportions as appropriate.